Phosphoprotein dynamics of interacting T cells and tumor cells by HySic

Cell Rep. 2024 Jan 23;43(1):113598. doi: 10.1016/j.celrep.2023.113598. Epub 2023 Dec 26.

Abstract

Functional interactions between cytotoxic T cells and tumor cells are central to anti-cancer immunity. However, our understanding of the proteins involved is limited. Here, we present HySic (hybrid quantification of stable isotope labeling by amino acids in cell culture [SILAC]-labeled interacting cells) as a method to quantify protein and phosphorylation dynamics between and within physically interacting cells. Using co-cultured T cells and tumor cells, we directly measure the proteome and phosphoproteome of engaged cells without the need for physical separation. We identify proteins whose abundance or activation status changes upon T cell:tumor cell interaction and validate our method with established signal transduction pathways including interferon γ (IFNγ) and tumor necrosis factor (TNF). Furthermore, we identify the RHO/RAC/PAK1 signaling pathway to be activated upon cell engagement and show that pharmacologic inhibition of PAK1 sensitizes tumor cells to T cell killing. Thus, HySic is a simple method to study rapid protein signaling dynamics in physically interacting cells that is easily extended to other biological systems.

Keywords: CP: Cancer; CP: Immunology; T cell; cancer; cell-cell interaction; immunology; phosphoproteomics; proteomics.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cell Communication
  • Humans
  • Isotope Labeling / methods
  • Neoplasms*
  • Phosphoproteins* / metabolism
  • Phosphorylation
  • Proteome / metabolism
  • Signal Transduction

Substances

  • Phosphoproteins
  • Proteome